(Total Views: 281)
Posted On: 12/18/2017 4:32:42 PM
Post# of 30015
![Avatar](https://investorshangout.com/images/ProfileImages/1435202243_13345_MANF (200x167).jpg)
Re: jamiejaytrader #25645
Rhopressa passed second phase III today in Glaucoma. First new treatment, not cure/prevention, in 25 years. Aerie Pharma is a company purely devoted to Glaucoma with a short but very successful pipeline that's about to be swimming in cash. They would be a stellar partner for MANF Tx.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)